ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $505,005 | -11.6% | 28,134 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $571,402 | +16.3% | 28,134 | +4.5% | 0.00% | 0.0% |
Q1 2023 | $491,222 | -11.8% | 26,931 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $556,933 | -19.5% | 26,931 | +1.8% | 0.00% | -33.3% |
Q3 2022 | $691,958 | +3.2% | 26,451 | 0.0% | 0.01% | +20.0% |
Q2 2022 | $670,268 | -15.2% | 26,451 | +5.6% | 0.01% | 0.0% |
Q1 2022 | $790,231 | +22.7% | 25,039 | +57.4% | 0.01% | 0.0% |
Q4 2021 | $643,959 | +16.1% | 15,912 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $554,851 | +9.8% | 15,912 | -13.5% | 0.01% | 0.0% |
Q2 2021 | $505,209 | -2.2% | 18,398 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $516,616 | +8.2% | 18,398 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $477,612 | +51.5% | 18,398 | 0.0% | 0.01% | +66.7% |
Q3 2020 | $315,342 | -18.5% | 18,398 | +17.6% | 0.00% | -25.0% |
Q2 2020 | $387,057 | +78.2% | 15,645 | 0.0% | 0.00% | +33.3% |
Q1 2020 | $217,153 | +37.4% | 15,645 | 0.0% | 0.00% | +50.0% |
Q4 2019 | $158,015 | +11.0% | 15,645 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $142,370 | +14.5% | 15,645 | 0.0% | 0.00% | +100.0% |
Q2 2019 | $124,378 | -36.3% | 15,645 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $195,406 | +16.0% | 15,645 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $168,497 | – | 15,645 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |